14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial .

Simple item page
dc.contributor.authorDiacon AH
dc.contributor.authorDawson R
dc.contributor.authorVon Groote-Bidlingmaier F
dc.contributor.authorSymons G
dc.contributor.authorVenter A
dc.contributor.authorDonald PR
dc.contributor.authorVan Niekerk C
dc.contributor.authorEveritt D
dc.contributor.authorWinter H
dc.contributor.authorBecker P
dc.contributor.authorMendel C
dc.contributor.authorSpigelman MK
dc.date.accessioned2013-07-03T08:18:51Z
dc.date.available2013-07-03T08:18:51Z
dc.date.issued2012
dc.descriptionGeneeskunde en Gesondheidswetenskappe
dc.descriptionGeneeskundige Fisiologie
dc.descriptionPlease help us populate SUNScholar with the post print version of this article. It can be e-mailed to: scholar@sun.ac.za
dc.identifier.citationLancet
dc.identifier.urihttp://hdl.handle.net/10019.1/81455
dc.publisherLANCET LTD, 84 THEOBALDS RD, LONDON, ENGLAND, WC1X 8RR
dc.title14-day bactericidal activity of PA-824, bedaquiline, pyrazinamide, and moxifloxacin combinations: a randomised trial .
dc.typeJournal Articles (subsidised)
Files
Collections
2012 - Research Outputs